Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

Nvidia ( NVDA -2.85%) has been the top AI investment since the AI arms race kicked off in 2023. Over that time frame, ...

Technical decisions that advance inference capabilities can help deliver the promise of ubiquitous, accessible AI.

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Chinese insurance broker TIRX to acquire Ucare Inc in $150 million all-share deal, enhancing role in health insurance sector through AI platform.

Connected drug delivery devices integrate digital connectivity — often via Bluetooth — with traditional drug administration ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Live Updates Live Coverage Updates appear automatically as they are published. Personal Income & Spending Preview 10:38 am by ...

The internet freaked out after Anthropic revealed that Claude attempts to report “immoral” activity to authorities under ...

Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced its participation in the ...

Google DeepMind published a paper describing their AlphaEvolve coding agent. AlphaEvolve uses LLMs to discover and optimize ...